Datametrex Provides Update On Health Canada Submission & Welcomes Advisors Emerging Technology Investing
Hydroxychloroquine Side Effects Potentially Mitigated by Transdermal Delivery Pharmaceutical Investing
Codebase Ventures: Hydroxychloroquine Treatment for COVID-19 Benefits Sought in Global Research Effort to Establish Efficacy Blockchain Investing
Revive Therapeutics Partners with Complete Phytochemical Solutions to Advance Research Initiatives for Psilocybin-Based Pharmaceutical Products Pharmaceutical Investing
Datametrex Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea Emerging Technology Investing
Relevium Reports $250,000 in Pre-Sales for Bioganix® CleanCare Hand Sanitizers in First 6 Days Pharmaceutical Investing
Revive Therapeutics Announces Closing of Second Tranche of Brokered Private Placement Pharmaceutical Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
